LAS VEGAS, NV--(Marketwired - Jun 7, 2016) - Alkame Holdings, Inc. (
HydrO²Pet's new lineup of Avian pet products include SKU's developed for both Ready to Use Nectars & Concentrates, as wells as assorted solutions for Hummingbirds, Orioles, and Exotic birds, everything from McCaw's to Parakeets. Product sizes range from 16oz to 2.5 gallon containers.
According to Robert Eakle, CEO of Alkame Holdings, Inc., "We are excited to start presenting and introducing our newest series in the HydrO²Pet line of pet products, utilizing our patented water treatment technology. We have had great success with these products in the past, and the demand for this new line has been encouraging. It's exciting to show the world another great new and improved application for the technology."
About Alkame Holdings, Inc.
Alkame Holdings, Inc. is a publicly traded health and wellness technology holding company, with a focus on patentable, innovative, and eco-friendly consumer products. The Company's wholly-owned subsidiaries market and distribute enhanced waters utilizing an exclusive patented formula and technology to create water with several unique properties, enabling an increase to available oxygen content, optimized pH levels, as well as the added benefits of electrolytes, and enhancement of antioxidant properties, equating into many potential health benefits, such as a reduced structure for permeability, improved metabolic efficiency, a boosted immune system, improved cardio respiratory function, and a decrease in lactic acid for faster muscle recovery. The organization is diligently building a strong foundation through the launch and acquisition of appropriate business assets, and by pursuing multiple applications to utilize its Intellectual Property by placement into several emerging business sectors, such as the growing aqua-culture industry, consumer bottled water and RTD products, household pet products, horticulture and agriculture applications, as well as many other various water treatment solutions to both new and existing business platforms.
For more information, visit www.hydro2pet.com.
Disclaimer/Safe Harbor: This news release contains forward-looking statements within the meaning of the Securities Litigation Reform Act. The statements reflect the Company's current views with respect to future events that involve risks and uncertainties. Among others, these risks include the expectation that Alkame will achieve significant sales, the failure to meet schedule or performance requirements of the Company's contracts, the Company's liquidity position, the Company's ability to obtain new contracts, the emergence of competitors with greater financial resources and the impact of competitive pricing. In the light of these uncertainties, the forward-looking events referred to in this release might not occur. These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure or prevent any disease.
Image Available: http://www2.marketwire.com/mw/frame_mw?attachid=3018721